Exploratory analysis of long-term suppressive therapy with dalbavancin in ventricular assist device infections caused by Staphylococcus aureus

Abstract To analyze dalbavancin’s potential for long-term suppressive therapy in patients with infected ventricular assist devices (VAD), the VAD register of Heidelberg University Hospital was searched for patients who received dalbavancin for long-term suppression therapy. Clinical data, laboratory...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Benedict Morath, Sabrina Klein, Ute Chiriac, Yvonne Müller, Lisa Koeppel, Otto Frey, Heike Lanzinger, Philipp Schlegel, Sonja Hamed, Dennis Nurjadi, Philipp Ehlermann, Matthias Karck, Anna L. Meyer
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Nature Portfolio 2025-05-01
Sarja:	Scientific Reports
Aiheet:	Dalbavancin Ventricular assist device Staphylococcus aureus Persistent infection
Linkit:	https://doi.org/10.1038/s41598-025-99112-7
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!